Browse by Uncontrolled Keywords
Number of items: 26.
2011
Bujkiewicz, S;
Jones, HE;
Lai, MC;
Cooper, NJ;
Hawkins, N;
Squires, H;
Abrams, KR;
Spiegelhalter, DJ;
Sutton, AJ;
(2011)
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.
Value in health, 14 (5).
pp. 768-76.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2010.12.002
2009
McKenna, C;
Palmer, S;
Rodgers, M;
Chambers, D;
Hawkins, N;
Golder, S;
van Hout, S;
Pepper, C;
Todd, D;
Woolacott, N;
(2009)
Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom.
Heart (British Cardiac Society), 95.
pp. 542-549.
ISSN 1355-6037
DOI: https://doi.org/10.1136/hrt.2008.147165
Full text not available from this repository.
Uzochukwu, BS;
Onwujekwe, OE;
Onoka, AC;
Okoli, C;
Uguru, NP;
Chukwuogo, OI;
(2009)
Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria.
Health policy and planning, 24 (3).
pp. 189-96.
ISSN 0268-1080
DOI: https://doi.org/10.1093/heapol/czp006
Full text not available from this repository.
2008
Onwujekwe, O;
Dike, N;
Chukwuka, C;
Uzochukwu, B;
Onyedum, C;
Onoka, C;
Ichoku, H;
(2008)
Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.
Health policy (Amsterdam, Netherlands), 90 (2-3).
pp. 223-9.
ISSN 0168-8510
DOI: https://doi.org/10.1016/j.healthpol.2008.10.006
Full text not available from this repository.
Ryan, M;
Griffin, S;
Chitah, B;
Walker, AS;
Mulenga, V;
Kalolo, D;
Hawkins, N;
Merry, C;
Barry, MG;
Chintu, C;
+2 more...
Sculpher, MJ;
Gibb, DM;
(2008)
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
AIDS (London, England), 22.
pp. 749-57.
ISSN 0269-9370
DOI: https://doi.org/10.1097/QAD.0b013e3282f43519
Full text not available from this repository.
2007
Bravo Vergel, Y;
Hawkins, NS;
Claxton, K;
Asseburg, C;
Palmer, S;
Woolacott, N;
Bruce, IN;
Sculpher, MJ;
(2007)
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.
Rheumatology (Oxford, England), 46.
pp. 1729-35.
ISSN 1462-0324
DOI: https://doi.org/10.1093/rheumatology/kem221
Full text not available from this repository.
Ebri, A;
Kuper, H;
Wedner, S;
(2007)
Cost-effectiveness of cycloplegic agents: Results of a randomized controlled trial in Nigerian children.
Investigative ophthalmology & visual science, 48 (3).
pp. 1025-1031.
ISSN 0146-0404
DOI: https://doi.org/10.1167/iovs.06-0604
Jit, M;
Edmunds, WJ;
(2007)
Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
Vaccine, 25 (20).
pp. 3971-9.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2007.02.070
Full text not available from this repository.
2006
Barrett, A;
Roques, T;
Small, M;
Smith, RD;
(2006)
How much will Herceptin really cost?
BMJ, 333 (7578).
pp. 1118-20.
ISSN 1468-5833
DOI: https://doi.org/10.1136/bmj.39008.624051.BE
Kachur, SP;
Black, C;
Abdulla, S;
Goodman, C;
(2006)
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.
Malaria journal, 5.
ISSN 1475-2875
DOI: https://doi.org/10.1186/1475-2875-5-25
Sinanovic, E;
Kumaranayake, L;
(2006)
Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
Tropical medicine & international health, 11 (9).
pp. 1466-1474.
ISSN 1360-2276
DOI: https://doi.org/10.1111/j.1365-3156.2006.01686.x
Full text not available from this repository.
2005
Gutierrez, JP;
Bertozzi, SM;
(2005)
[Influenza vaccination in the elderly population in Mexico: economic considerations].
Salud publica de Mexico, 47 (3).
pp. 234-9.
ISSN 0036-3634
DOI: https://doi.org/10.1590/S0036-36342005000300007
2004
Gutierrez, JP;
Johns, B;
Adam, T;
Bertozzi, SM;
Edejer, TT;
Greener, R;
Hankins, C;
Evans, DB;
(2004)
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
Lancet, 364 (9428).
pp. 63-4.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(04)16590-2
Full text not available from this repository.
Jones, L;
Griffin, S;
Palmer, S;
Main, C;
Orton, V;
Sculpher, M;
Sudlow, C;
Henderson, R;
Hawkins, N;
Riemsma, R;
(2004)
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation.
Health technology assessment (Winchester, England), 8 (38).
iii-iv, 1-196.
ISSN 1366-5278
https://researchonline.lshtm.ac.uk/id/eprint/2545583
Melegaro, A;
Edmunds, WJ;
(2004)
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Vaccine, 22 (31-32).
pp. 4203-14.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2004.05.003
Full text not available from this repository.
2003
Grieve, R;
Thompson, S;
Normand, C;
Suri, R;
Bush, A;
Wallis, C;
(2003)
A cost-effectiveness analysis of rhDNase in children with cystic fibrosis.
International journal of technology assessment in health care, 19 (1).
pp. 71-9.
ISSN 0266-4623
DOI: https://doi.org/10.1017/S0266462303000072
Marks, D;
Thorogood, M;
Neil, HA;
Wonderling, D;
Humphries, SE;
(2003)
Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
Journal of public health medicine, 25 (1).
pp. 47-52.
ISSN 0957-4832
DOI: https://doi.org/10.1093/pubmed/fdg010
Full text not available from this repository.
Pepin, J;
Mabey, D;
(2003)
Sexually transmitted infections in Africa: single dose treatment is now affordable.
Sexually transmitted infections, 79 (6).
pp. 432-4.
ISSN 1368-4973
DOI: https://doi.org/10.1136/sti.79.6.432
Full text not available from this repository.
2002
Boulle, A;
Kenyon, C;
Skordis, J;
Wood, R;
(2002)
Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
South African Medical Journal, 92 (10).
pp. 811-7.
ISSN 0256-9574
https://researchonline.lshtm.ac.uk/id/eprint/11150
Harries, AD;
Hargreaves, NJ;
Chimzizi, R;
Salaniponi, FM;
(2002)
Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
Bulletin of the World Health Organization, 80 (6).
pp. 464-9.
ISSN 0042-9686
https://researchonline.lshtm.ac.uk/id/eprint/8901
Schroeder, K;
Ebrahim, S;
Fahey, T;
Montgomery, A;
Peters, T;
(2002)
Daily regimen and compliance with treatment. All available evidence needs to be evaluated.
BMJ, 324 (7334).
p. 425.
ISSN 1468-5833
DOI: https://doi.org/10.1136/bmj.324.7334.425
Suri, R;
Grieve, R;
Normand, C;
Metcalfe, C;
Thompson, S;
Wallis, C;
Bush, A;
(2002)
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
Thorax, 57 (10).
pp. 841-6.
ISSN 0040-6376
DOI: https://doi.org/10.1136/thorax.57.10.841
Full text not available from this repository.
2001
Feachem, R;
(2001)
HAART--the need for strategically focused investments.
Bulletin of the World Health Organization, 79 (12).
pp. 1152-3.
ISSN 0042-9686
https://researchonline.lshtm.ac.uk/id/eprint/10958
Goodman, CA;
Coleman, PG;
Mills, AJ;
(2001)
Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
Health economics, 10 (8).
pp. 731-49.
ISSN 1057-9230
DOI: https://doi.org/10.1002/hec.621
Full text not available from this repository.
Holloway, KA;
Gautam, BR;
Reeves, BC;
(2001)
The effects of different kinds of user fee on prescribing costs in rural Nepal.
Health policy and planning, 16 (4).
pp. 421-7.
ISSN 0268-1080
https://researchonline.lshtm.ac.uk/id/eprint/17312
Full text not available from this repository.
Mason, J;
Freemantle, N;
Nazareth, I;
Eccles, M;
Haines, A;
Drummond, M;
(2001)
When is it cost-effective to change the behavior of health professionals?
JAMA, 286 (23).
pp. 2988-2992.
ISSN 0098-7484
DOI: https://doi.org/10.1001/jama.286.23.2988